Gaps and Disparities in the Hepatitis B Cascade of Care Among a National Cohort of U.S. Veterans with Chronic Hepatitis B Infection

Less than one-third of Veterans with CHB eligible for treatment received antiviral therapy. A major contributor to gaps in treatment are due to lack of routine laboratory monitoring and GI/Hepatology clinic follow-up. Efforts aimed at improving timely CHB treatment should focus resources to ensure appropriate linkage and retention to specialty care with routine CHB monitoring.